Try a new search

Format these results:

Searched for:

person:rotroj01 or bogenm02 or hanseh03 or lewisc12 or Sarah Mennenga or rosss01 or kc16

Total Results:

877


Conformational changes in muscarinic receptors may produce diminished cholinergic neurotransmission and memory deficits in aged rats

Lippa AS; Loullis CC; Rotrosen J; Cordasco DM; Critchett DJ; Joseph JA
Both clinical and laboratory studies suggest that age-related memory deficits may be due, at least in part, to disturbances in muscarinic acetylcholine (mAChR) receptors. In order to further evaluate this premise, the present studies examined the electrophysiological responses rates of hippocampal pyramidal cells to iontophoretically applied ACh in young, middle-age and aged animals. The relationship between age and muscarinic agonist and antagonist binding in the hippocampus was also examined. In addition, possible age-related changes in receptor-effector coupling were assessed by determining calmodulin levels and the activities of phospholipid methyl-transferase I and II. Analysis of electrophysiological data showed selective age-related decrements in the ability of ACh to alter burst rate but not simple spike rate. These age-related decreases in the efficacy of ACh to increase burst rate were not paralleled by decreases in mAChR density as assessed by 3H-QNB binding, but they were temporally paralleled by age-related changes in the ability of oxotremorine to inhibit 3H-QNB binding. In the young animals, the resultant Hill coefficients derived from these analyses approached 1, while in the middle and old aged animals, the Hill coefficients deviated significantly from 1, indicating the possible existence of 2 or more receptor states with differential affinity for oxotremorine in the 2 older age groups. When carbamylcholine was used to inhibit 3H-QNB, these complex binding patterns were seen even in the young, since carbamylcholine induces conformational/orientational changes in the mAChR while oxotremorine does not.(ABSTRACT TRUNCATED AT 250 WORDS)
PMID: 3003612
ISSN: 0197-4580
CID: 23629

Amphetamine response and relapse risk after depot neuroleptic discontinuation

Angrist B; Peselow E; Rubinstein M; Wolkin A; Rotrosen J
Twenty-five schizophrenic outpatient subjects in a depot neuroleptic discontinuation study received an amphetamine challenge approximately 6 weeks after their last dose. Only five of these showed greater than three-point increases in positive symptoms on the BPRS, and all five relapsed within 30 days of the challenge. The 20 with less than three-point increases in positive symptoms showed extremely variable stability, relapsing from 20- greater than 600 days after the challenge. Thus, increase in positive symptoms after amphetamine may identify a group at risk for rapid relapse after neuroleptic discontinuation, but lack of such a response gives little prognostic information
PMID: 2860683
ISSN: 0033-3158
CID: 23630

The prevalence of tardive dyskinesia

Kane JM; Woerner M; Lieberman JA; Weinhold P; Florio W; Rubinstein M; Rotrosen J; Kurucz J; Mukherjee S; Bergmann K; et al.
PMID: 2858906
ISSN: 0048-5764
CID: 23631

AVERSION-GATING SITES IN LATERAL HYPOTHALAMUS AN ANATOMIC AND PHARMACOLOGIC STUDY [Meeting Abstract]

CARR K D; UYSAL S
BIOSIS:PREV198630104211
ISSN: 0190-5295
CID: 92236

Murine lymphocytes lack clearly defined receptors for muscarinic and dopaminergic ligands

Wazer DE; Rotrosen J
[3H]Quinuclidinyl benzilate and [3H]spiperone binding to murine lymphocytes is displaceable but differs from binding to brain receptor sites for these ligands: (1) binding to intact lymphocyte preparations was not saturable; (2) disruption of intact lymphocytes was associated with a marked loss of displaceable ligand binding; (3) drugs differentially displace these ligands in lymphocytes compared to brain. Displaceable binding was increased following incubation of lymphocytes under phospholipid methylating conditions; however, marked effects on cell viability and cell recovery make it difficult to interpret these binding changes. If dopaminergic and cholinergic receptors do exist on lymphocytes, their binding characteristics are profoundly different from comparable cns receptors
PMID: 6151985
ISSN: 0022-3573
CID: 23632

Analgesic effects of ethylketocyclazocine and morphine in rat and toad

Carr KD; Aleman DO; Holland MJ; Simon EJ
We have previously found rat and toad (Bufo marinus) brain to contain inverse ratios of benzomorphan-preferring (kappa/sigma) and morphine-preferring (mu) opioid receptor types. The aim of the present study was to compare in vivo pharmacologic activity of a benzomorphan, ethylketocyclazocine (EKC) and morphine sulfate (MS) in rat and toad. Footshock intensity thresholds for eliciting locomotion were determined and dose-response curves for EKC and MS analgesia were obtained. Drugs were injected subcutaneously. In rats (high mu, low kappa in brain), both compounds produced analgesia and displayed similar sensitivity to naloxone antagonism. The analgesic effects of EKC and MS may, therefore, be mediated by a common receptor type (mu) in this pain test in rats. In toads (high kappa, low mu in brain), MS produced naloxone-reversible analgesia at doses 20-fold higher than were effective in rats. Toads did not display EKC analgesia at doses below those producing motor impairment. Moreover, 50-fold higher doses were required to produce such impairment in toads. Thirty minutes following subcutaneous injection of 3H-EKC, similar concentrations were found in rat and toad brain. Uptake into brain is probably not a factor in the behavioral resistance of toads to EKC
PMID: 6433131
ISSN: 0024-3205
CID: 63650

Side effects of scopolamine administration [Letter]

Serby M; Corwin J; Jordan B; Novatt A; Rotrosen J
PMID: 6465355
ISSN: 0002-953x
CID: 23633

TRH test abnormalities in psychiatric disorders

Wolkin A; Peselow ED; Smith M; Lautin A; Kahn I; Rotrosen J
Blunted responses to thyrotropin-releasing hormone (TRH) stimulation have been found consistently in depressed patients, and have been reported in other affective disorders as well. In a smaller number of schizophrenic subjects, TRH tests have generally been normal. Thus, it has been suggested that this test may have diagnostic utility in distinguishing schizophrenia from affective disorders. In the present study the TRH test was performed upon a sample of 51 subjects that included 17 schizophrenics in order to further study the diagnostic or symptom specificity of this endocrine test. Abnormal TRH tests were present in both schizophrenic and affectively disturbed patients. There were no correlations with ratings of depression or other aspects of psychopathology. Factors which may have previously obscured abnormal TRH tests in schizophrenia are discussed
PMID: 6235258
ISSN: 0165-0327
CID: 23634

Abuse of the elderly: screening and detection

Fulmer, T; Street, S; Carr, K
PMID: 6374226
ISSN: 0099-1767
CID: 156261

Potentiation of reward by hunger is opioid mediated

Carr KD; Simon EJ
In tests of frequency threshold for brain stimulation-induced feeding, naloxone (s.c.) did not affect the first in a brief series of threshold estimates but elevated subsequent estimates progressively. It was demonstrated that neither the time-course of drug action nor any cumulative disruptive effect of brain stimulation itself, accounts for the progressive elevation of threshold. Self-stimulation in 'feeding' electrodes was therefore studied, in combination with hunger manipulations, to inferentially evaluate naloxone's effect on feeding mechanisms. Results suggest naloxone's anoretic effect does not reflect heightened responsiveness of a satiety mechanism. Reversal by naloxone of the potentiating effect of hunger on self-stimulation, however, suggests the anoretic effect is due to blockade of an opioid process associated with hunger that otherwise enhances the reward value of food
PMID: 6326944
ISSN: 0006-8993
CID: 63651